Expert in Clinical Trials and Development of Prostate Cancer Agents Joins Kimmel Cancer Center at Jefferson
William Kevin Kelly, DO, has been appointed Director of the Solid Tumor Oncology Division in the Department of Medical Oncology with a joint appointment in the Department of Urology at Jefferson Medical College of Thomas Jefferson University, as well as Associate Director of Translational Research at the Kimmel Cancer Center at Jefferson.
Dr. Kelly, who comes from Yale University School of Medicine with more than 20 years of clinical and investigational experience, is a highly dedicated clinician, clinical investigator, and educator. He will play a pivotal role in re-shaping and enhancing clinical research within the Kimmel Cancer Center and in building new clinical programs within the Department of Medical Oncology.
Dr. Kelly is known for his expertise in the design and conduct of clinical trials. He is also regarded as an internationally respected expert in the development of novel treatment strategies and targeted agents for prostate cancer and other urologic cancers. Dr. Kelly has been instrumental in the development of multiple compounds such as microtubule disrupting agents, histone deacetylase inhibitors, and anti-angiogenesis therapies for urologic cancers.
He continues to work closely with scientists, as well as with investigators in industry, to develop these agents. At Yale University School of Medicine, Dr. Kelly held the positions of Associate Professor of Medicine and Surgery, Medical Director of the Clinical Research Service, Director of the Solid Tumor Clinical Investigation Program and Co-Director of the Prostate and Urological Oncology Program.
He earned his undergraduate degree from Emory University and received his DO from Philadelphia College of Osteopathic Medicine. Dr. Kelly did his residency at Albert Einstein Medical Center, and then completed his fellowship training in medical oncology at Memorial-Sloan Kettering Cancer Center. He subsequently was on the faculty at Memorial-Sloan Kettering Cancer Center for 15 years before joining Yale University.
Dr. Kelly serves on numerous editorial boards such as Journal of Clinical Oncology, Clinical Prostate Cancer, Nature Clinical Practice.
Media Only Contact:
Jackie Kozloski
Thomas Jefferson University Hospital
Phone: (215) 955-6300
Published: 12/7/2010